"Black Hole" of medical research–Negative Results Don’t get Published – JAMA, WSJ

“Black Hole” of medical research–Negative Results Don’t get Published – JAMA, WSJ Sat, 5 Jun 2004 “No one likes bad news. But in science, there is an ethical imperative to publish research, even if the findings aren’t what the researcher had hoped for.” The New York Times, which tends to…

Pfizer Statements RE: Bextra, Celebrex, Neurontin Shown to be Lies

Pfizer Statements RE: Bextra, Celebrex, Neurontin Shown to be Lies Fri, 08 Apr 2005 The New York Times reports that “as recently as Tuesday [Pfizer] assured Wall Street that sales of Celebrex and Bextra would soon rebound. It was the latest in a string of announcements by the company regarding…

Research at US Veterans Hospitals Nationwide Under Investigation_NYT

Research at US Veterans Hospitals Nationwide Under Investigation_NYT Sun, 13 Apr 2003 Veterans returning from service in the military deserve better than the medical care that awaits them at the nation’s Veterans Affairs (VA) medical centers. The Associated Press reported on Friday, April 11, that a study shows that patients…

Infomail Archive

July 9, 2002 Oregonian Editorial: Stop Drug Research on Oregon Kids FYI "…there is no question that suspicionless drug testing, particularly when combined with an outside research study, is an ethical morass and an abuse of school power." Those who approved this experiment have transgressed their authority, teaching children the…

FDA Approves Lilly’s Growth Hormone for Healthy Children

FDA Approves Lilly’s Growth Hormone for Healthy Children Mon, 28 Jul 2003 The FDA has approved Eli Lilly’s injectable human growth hormone (hGH) therapy, Humatrope, for healthy children who are short but have no hormonal deficiency. Lilly claims that its trials in 300 healthy short children resulted in an increase…

UK Chanel 4 Investigates: The Drug Trial That Went Wrong_Critique NEJM Editorial

“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of  TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm  It airs momorrow.